58
In band
Moving averages
SMA 200$7.32-33.88%
Company profile
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$640.16M
P/E ratioNone
EPS$-1.09
Beta1.921
Dividend yield0.00%
52-week high$23.20
52-week low$3.67
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 58
CGC
Canopy Growth Corporation
RSI 64
BFRI
Biofrontera Inc
RSI 75
LNTH
Lantheus Holdings Inc
RSI 42
ACB
Aurora Cannabis Inc
RSI 73
BCRX
Biocryst Pharmaceuticals Inc
RSI 49
INM
InMed Pharmaceuticals Inc
RSI 46
ORGO
Organogenesis Holdings Inc - Class A
RSI 35
ZTS
Zoetis Inc - Class A
RSI 57
AQST
Aquestive Therapeutics Inc
RSI 52
RSI alerts for TLRY
Get an email the moment Tilray Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 14 August 2026 at 8:14 AM EDT